📰 Pegylated Interferon Lambda News
Pegylated Interferon Lambda News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Pegylated Interferon Lambda. Real-time updates on events, politics, business and more.
February 10, 2023
In a recent study published in The New England Journal of Medicine, researchers used the TOGETHER platform trial protocol to perform a phase III randomized controlled trial (RCT) to evaluate the effectiveness of pegylated interferon (IFN) lambda (λ) therapy in outpatients with coronavirus disease 2019 (COVID-19) in Canada and Brazil.
February 10, 2023
Today's Water Cooler
February 9, 2023
It involves one dose of pegylated interferon lambda, a synthetic version of a naturally occurring protein that infected cells secrete to defend against viral infection
February 9, 2023
The data look quite promising and other treatments have now fallen by the wayside, said Paul Sax, MD, of Brigham and Womens Hospital in Boston.
February 8, 2023
/PRNewswire/ -- Eiger BioPharmaceuticals Inc. (Nasdaq: EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies...